These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 23992922)

  • 1. Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles.
    Kanazawa T; Akiyama F; Kakizaki S; Takashima Y; Seta Y
    Biomaterials; 2013 Dec; 34(36):9220-6. PubMed ID: 23992922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of life in rats with malignant glioma by intranasal siRNA/drug codelivery to the brain with cell-penetrating peptide-modified micelles.
    Kanazawa T; Morisaki K; Suzuki S; Takashima Y
    Mol Pharm; 2014 May; 11(5):1471-8. PubMed ID: 24708261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration.
    Kanazawa T; Taki H; Tanaka K; Takashima Y; Okada H
    Pharm Res; 2011 Sep; 28(9):2130-9. PubMed ID: 21499835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
    Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nose-to-brain drug delivery system with ligand/cell-penetrating peptide-modified polymeric nano-micelles for intracerebral gliomas.
    Kanazawa T; Taki H; Okada H
    Eur J Pharm Biopharm; 2020 Jul; 152():85-94. PubMed ID: 32387702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
    Kanazawa T
    Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery.
    Tanaka K; Kanazawa T; Shibata Y; Suda Y; Fukuda T; Takashima Y; Okada H
    Int J Pharm; 2010 Aug; 396(1-2):229-38. PubMed ID: 20600726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal delivery of camptothecin-loaded tat-modified nanomicells for treatment of intracranial brain tumors.
    Taki H; Kanazawa T; Akiyama F; Takashima Y; Okada H
    Pharmaceuticals (Basel); 2012 Oct; 5(10):1092-102. PubMed ID: 24281259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
    Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
    Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of nose-to-brain delivery of hydrophilic macromolecules with stearate- or polyethylene glycol-modified arginine-rich peptide.
    Kanazawa T; Kaneko M; Niide T; Akiyama F; Kakizaki S; Ibaraki H; Shiraishi S; Takashima Y; Suzuki T; Seta Y
    Int J Pharm; 2017 Sep; 530(1-2):195-200. PubMed ID: 28757255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Small interfering RNA delivery mediated by mPEG-PCL-g-PEI polymer nanoparticles].
    Huang W; Lü M; Gao ZG; Jin MJ; Yang CQ
    Yao Xue Xue Bao; 2011 Mar; 46(3):344-9. PubMed ID: 21626792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles.
    Kanazawa T; Kurano T; Ibaraki H; Takashima Y; Suzuki T; Seta Y
    Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31540164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic delivery of siRNA to the colon using peptide modified PEG-PCL polymer micelles for the treatment of ulcerative colitis.
    Ibaraki H; Hatakeyama N; Arima N; Takeda A; Seta Y; Kanazawa T
    Eur J Pharm Biopharm; 2022 Jan; 170():170-178. PubMed ID: 34963657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
    Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J
    Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
    Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
    Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer's therapy.
    Rassu G; Soddu E; Posadino AM; Pintus G; Sarmento B; Giunchedi P; Gavini E
    Colloids Surf B Biointerfaces; 2017 Apr; 152():296-301. PubMed ID: 28126681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
    Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
    Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
    Liu P; Yu H; Sun Y; Zhu M; Duan Y
    Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical characterization of hyper-branched polyethylenimine-graft-polycaprolactone-block-mono-methoxyl-poly(ethylene glycol) copolymers (hy-PEI-PCL-mPEG) for siRNA delivery.
    Liu Y; Samsonova O; Sproat B; Merkel O; Kissel T
    J Control Release; 2011 Aug; 153(3):262-8. PubMed ID: 21549166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway.
    Renner DB; Frey WH; Hanson LR
    Neurosci Lett; 2012 Apr; 513(2):193-7. PubMed ID: 22387067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.